Clinical Trial Update: Optimum Insufflation Capacity in NMD [NA]

View source ↗

Summary

This ClinicalTrials.gov update for NCT01981915 indicates completion of a study on optimum insufflation capacity in neuromuscular diseases, including Duchenne mu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy
• Respiratory Insufficiency
• Spinal Muscular Atrophy

Snippet

Sponsor: Universität Duisburg-Essen | Conditions: Duchenne Muscular Dystrophy, Spinal Muscular Atrophy | NA | Status: COMPLETED